India
· Delayed Price · Currency is INR Lincoln Pharmaceuticals Statistics
Total Valuation
BOM:531633 has a market cap or net worth of INR 11.36 billion. The enterprise value is 9.40 billion.
| Market Cap | 11.36B |
| Enterprise Value | 9.40B |
Important Dates
The next estimated earnings date is Tuesday, May 20, 2025.
| Earnings Date | May 20, 2025 |
| Ex-Dividend Date | Sep 13, 2024 |
Share Statistics
BOM:531633 has 20.03 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 20.03M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 50.88% |
| Owned by Institutions (%) | 1.69% |
| Float | 8.65M |
Valuation Ratios
The trailing PE ratio is 12.72.
| PE Ratio | 12.72 |
| Forward PE | n/a |
| PS Ratio | 1.90 |
| PB Ratio | 1.78 |
| P/TBV Ratio | 1.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 10.52 |
| EV / Sales | 1.57 |
| EV / EBITDA | 10.14 |
| EV / EBIT | 11.60 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | n/a |
| Interest Coverage | 54.19 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.54% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 3.54M |
| Profits Per Employee | 529,747 |
| Employee Count | 1,687 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.72% in the last 52 weeks. The beta is 0.34, so BOM:531633's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -2.72% |
| 50-Day Moving Average | 557.67 |
| 200-Day Moving Average | 677.03 |
| Relative Strength Index (RSI) | 49.22 |
| Average Volume (20 Days) | 4,189 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:531633 had revenue of INR 5.98 billion and earned 893.68 million in profits. Earnings per share was 44.61.
| Revenue | 5.98B |
| Gross Profit | 3.09B |
| Operating Income | 810.97M |
| Pretax Income | 1.15B |
| Net Income | 893.68M |
| EBITDA | 926.92M |
| EBIT | 810.97M |
| Earnings Per Share (EPS) | 44.61 |
Balance Sheet
The company has 1.97 billion in cash and 13.55 million in debt, giving a net cash position of 1.96 billion or 97.88 per share.
| Cash & Cash Equivalents | 1.97B |
| Total Debt | 13.55M |
| Net Cash | 1.96B |
| Net Cash Per Share | 97.88 |
| Equity (Book Value) | 6.39B |
| Book Value Per Share | 319.26 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 51.65%, with operating and profit margins of 13.57% and 14.96%.
| Gross Margin | 51.65% |
| Operating Margin | 13.57% |
| Pretax Margin | 19.27% |
| Profit Margin | 14.96% |
| EBITDA Margin | 15.51% |
| EBIT Margin | 13.57% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.80, which amounts to a dividend yield of 0.33%.
| Dividend Per Share | 1.80 |
| Dividend Yield | 0.33% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | 0.30% |
| Earnings Yield | 7.86% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on March 19, 2009. It was a reverse split with a ratio of 0.2.
| Last Split Date | Mar 19, 2009 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |